SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-14-005169
Filing Date
2014-11-06
Accepted
2014-11-06 16:19:52
Documents
10
Period of Report
2014-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nerv-10q_20140930.htm 10-Q 1288940
2 EX-31.1 nerv-ex311_201409306.htm EX-31.1 15603
3 EX-31.2 nerv-ex312_201409307.htm EX-31.2 15425
4 EX-32.1 nerv-ex321_201409308.htm EX-32.1 9913
  Complete submission text file 0001564590-14-005169.txt   6077148

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT nerv-20140930.xml EX-101.INS 734578
6 XBRL TAXONOMY EXTENSION SCHEMA nerv-20140930.xsd EX-101.SCH 47104
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nerv-20140930_cal.xml EX-101.CAL 45265
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nerv-20140930_def.xml EX-101.DEF 190418
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nerv-20140930_lab.xml EX-101.LAB 345839
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nerv-20140930_pre.xml EX-101.PRE 322783
Mailing Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451
Business Address 1601 TRAPELO ROAD SUITE 284 WALTHAM MA 02451 617-600-7373
Minerva Neurosciences, Inc. (Filer) CIK: 0001598646 (see all company filings)

IRS No.: 260784194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36517 | Film No.: 141200956
SIC: 2834 Pharmaceutical Preparations